Login to Your Account



Patent Disclosures


Wednesday, January 15, 2014

Pluristem Therapeutics Inc., of Haifa, Israel, was issued Australian patent No. 2008300185, “Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced thereby for Therapy,” which covers the use of adherent placental cells for the treatment of ischemia, a restriction of blood supply to tissues, and for treatments of conditions that require connective tissue repair or regeneration.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription